Skip to content Skip to footer
20 Innovative Digital Therapeutics Companies of 2025

20 Innovative Digital Therapeutics Companies of 2025 

Shots:  The integration of innovative technologies in healthcare, such as digital health platforms and AI-enabled applications, is transforming the way diseases are detected, diagnosed, treated, and prevented The global Digital Health market is expected to reach $197.88B in 2025 and grow at a CAGR of 6.88%, reaching $258.25B by 2029 PharmaShots presents a concise report…

Read more

Innovative orthodontic solutions revolutionizing patient care and treatment results

Innovative orthodontic solutions revolutionizing patient care and treatment results

The field of orthodontics is undergoing a significant transformation, driven by cutting-edge technologies and patient-centric approaches. Innovations in this area are not only enhancing treatment outcomes but also revolutionizing the overall patient experience. As these advancements continue to evolve, they are shaping the future landscape of orthodontic care.The evolving landscape of orthodontic care is…

Read more

Pre-Conference Interviews ISPE Singapore Conference & Exhibition 2023

Pre-Conference Interviews: ISPE Singapore Conference & Exhibition 2023

The ISPE Singapore Affiliate Conference & Exhibition is one of the largest and most renowned pharmaceutical manufacturing shows in Singapore for pharmaceutical and biomanufacturing professionals. The annual event highlights the best practices and services from manufacturing facility design to finished products.Click here to register now!We are thrilled to announce that we are taking the…

Read more

Spotlight Interview_Bruce Bauer & Kendall Morrison

Spotlight Interview with Bruce Bauer (CEO) & Kendall Morrison (CSO) at TAE Life Sciences

PharmaShots conducted its fourth “Spotlight- Company of the Month with TAE Life Sciences”. In conversation with Bruce Bauer (CEO) & Kendall Morrison (CSO) at TAE Life Sciences, they both shared insights on TAE Life Sciences' vision, upcoming plans, technologies used, and developing products. Bruce and Kendall spoke about TAE’s novel treatment options which could potentially…

Read more

Viewpoints_Michael Scheffler

Michael Scheffler, Vice President, Head of Life Science PCR at QIAGEN Shares Insights on the Addition of New Biopharma Products to its Digital PCR Portfolio

Shots:Michael spoke about the addition of new biopharma products through QIAcuity series of digital PCR (dPCR) instruments to its digital PCR portfolioHe also talked about how QIAGEN’s dPCR assays are quicker than systems as it was launched in four different master mixes allowing experiments leading to precise resultsThe interview gives an understanding of…

Read more